An Exploratory Study of the Safety and Efficacy of a Trigonella foenum-graecum Seed Extract in Early Glucose Dysregulation: A Double-Blind Randomized Placebo-Controlled Trial

被引:6
|
作者
Pickering, Emily [1 ,2 ]
Steels, Elizabeth [1 ,2 ]
Rao, Amanda [3 ]
Steadman, Kathryn J. [1 ]
机构
[1] Univ Queensland, Sch Pharm, Brisbane, Qld 4102, Australia
[2] Evidence Sci Pty Ltd, Brisbane, Qld 4005, Australia
[3] Univ Queensland, Sch Human Movement & Nutr Sci, Brisbane, Qld 4102, Australia
关键词
Trigonella foenum-graecum; fenugreek; prediabetes; type; 2; diabetes; fasting blood glucose; post-prandial glucose; insulin; FENUGREEK SEEDS; INSULIN-RESISTANCE; BLOOD-GLUCOSE; TYPE-2; L; 4-HYDROXYISOLEUCINE; HYPERGLYCEMIA; STRESS;
D O I
10.3390/pharmaceutics14112453
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Background: This was an exploratory study to assess the safety and efficacy of a specialized Trigonella foenum-graceum L. seed extract for supporting healthy blood glucose metabolism in a pre-diabetic cohort. Methods: Fifty-four participants were randomised to receive 500 mg/day of T. foenum-graecum seed extract or matching placebo daily for 12 weeks. Fasting blood glucose (FBG), post-prandial glucose (PPBG), HbA1c, fasting insulin (FI), post-prandial insulin (PPI) and C-peptide were assessed at baseline, week 6 and week 12. Lipid levels, liver enzymes and C-reactive protein (CRP), along with safety markers and tolerability were also assessed at baseline and week 12. Results: By week 12 there was a significant difference in FBG (p < 0.001), PPBG (p = 0.007) and triglycerides (p = 0.030) between treatment groups, with no changes in HbA1c (p = 0.41), FI (p = 0.12), PPI (p = 0.50) or C-peptide (p = 0.80). There was no difference in total cholesterol (p = 0.99), high-density lipoprotein (p = 0.35), low density lipoprotein (p = 0.60) or CRP (p = 0.79). There was no change in safety markers and the treatment was well tolerated. Conclusions: The results of the study indicated that T. foenum-graecum seed extract may influence blood glucose metabolism and larger studies are warranted to evaluate efficacy and potential mechanisms of action.
引用
收藏
页数:13
相关论文
共 50 条
  • [1] EFFICACY AND SAFETY OF A MIXED EXTRACT OF TRIGONELLA FOENUM-GRAECUM SEED AND LESPEDEZA CUNEATA IN THE TREATMENT OF TESTOSTERONE DEFICIENCY SYNDROME: A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED CLINICAL TRIAL
    Park, N. C. P.
    Park, H. J.
    Lee, K. S.
    JOURNAL OF SEXUAL MEDICINE, 2019, 16 (04): : S62 - S62
  • [2] EFFICACY AND SAFETY OF A MIXED EXTRACT OF TRIGONELLA FOENUM-GRAECUM SEED AND LESPEDEZA CUNEATA IN THE TREATMENT OF TESTOSTERONE DEFICIENCY SYNDROME: A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED CLINICAL TRIAL
    Park, Hyun Jun
    Lee, Kyeong Soo
    Lee, Eun Kyoung
    Park, Nam Cheol
    JOURNAL OF UROLOGY, 2019, 201 (04): : E387 - E387
  • [3] Efficacy and Safety of a Mixed Extract of Trigonella foenum-graecum Seed and Lespedeza cuneata in the Treatment of Testosterone Deficiency Syndrome: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial
    Park, Hyun Jun
    Lee, Kyeong Soo
    Lee, Eun Kyoung
    Park, Nam Cheol
    WORLD JOURNAL OF MENS HEALTH, 2018, 36 (03): : 230 - 238
  • [4] Efficacy of a Proprietary Fenugreek Seed Extract (Trigonella foenum-graecum, Furocyst®) in Women with Polycystic Ovary Syndrome (PCOS): a Randomized, Double-Blind, Placebo-Controlled Study
    Singh, Amarjeet
    Gainder, Shalini
    Banerjee, Pradipta
    Goel, Apurva
    Kumar, Pawan
    Mondal, Banashree
    Banik, Samudra P.
    Bagchi, Debasis
    JOURNAL OF THE AMERICAN NUTRITION ASSOCIATION, 2023, 42 (07): : 651 - 659
  • [5] A Placebo-Controlled, Double-Blind Clinical Investigation to Evaluate the Efficacy of a Patented Trigonella foenum-graecum Seed Extract "Fenfuro®" in Type 2 Diabetics
    Hota, Debasish
    Padhy, Biswa M.
    Maiti, Rituparna
    Bisoi, Debasis
    Sahoo, Jyoti Prakash
    Patro, Binod K.
    Kumar, Pawan
    Goel, Apurva
    Banik, Samudra P.
    Chakraborty, Sanjoy
    Rungta, Mehul
    Bagchi, Manashi
    Bagchi, Debasis
    JOURNAL OF THE AMERICAN NUTRITION ASSOCIATION, 2024, 43 (02): : 147 - 156
  • [6] Efficacy of a Proprietary Trigonella foenum-graecum L. De-Husked Seed Extract in Reducing Menopausal Symptoms in Otherwise Healthy Women: A Double-Blind, Randomized, Placebo-Controlled Study
    Steels, E.
    Steele, M. L.
    Harold, M.
    Coulson, S.
    PHYTOTHERAPY RESEARCH, 2017, 31 (09) : 1316 - 1322
  • [7] A multi-centric placebo-controlled double-blind clinical study to determine the efficacy of a novel fenugreek seed (Trigonella foenum-graecum, Fenfuro™) extract in patients with Type 2 diabetes: an add-on study
    Verma, N. S.
    Siddiquee, K. U.
    Awasthi, V.
    Jain, A.
    Dhakre, S.
    Goel, P. K.
    Lamgora, G.
    Sehgal, R.
    DIABETIC MEDICINE, 2016, 33 : 9 - 9
  • [8] Influence of a specialized Trigonella foenum-graecum seed extract (Libifem), on testosterone, estradiol and sexual function, a randomized placebo controlled study
    Rao, Amanda
    Steels, Elizabeth
    Vitetta, Luis
    Inder, Warrick
    Beccaria, Gavin
    MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY, 2014, 21 (12): : 1360 - 1361
  • [9] Effect of a plant extract of fenugreek (Trigonella foenum-graecum) on testosterone in blood plasma and saliva in a double blind randomized controlled intervention study
    Lee-Odegard, Sindre
    Gundersen, Thomas E.
    Drevon, Christian A.
    PLOS ONE, 2024, 19 (09):
  • [10] Efficacy and safety of berberine for dyslipidemia: study protocol for a randomized double-blind placebo-controlled trial
    Ying Zhao
    Yuan-Yuan Yang
    Bao-Lin Yang
    Ya-Wei Du
    Da-Wei Ren
    Hong-Mei Zhou
    Jing Wang
    Hui-Min Yang
    Yao-Xian Wang
    Ying-Ying Zhang
    Sheng-Xian Wu
    Trials, 22